Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hogan & Hartson

This article was originally published in The Tan Sheet

Executive Summary

FDA Office of the Chief Counsel Senior Drugs Attorney and Supervisor David Fox joins D.C. law firm as partner. Fox was named FDA senior drugs attorney in 1997; he joined the agency in 1994. During his tenure, Fox was highly involved in OTC drug regulation, providing input during the drafting of the OTC labeling final rule and sitting in on several subsequent feedback meetings. Fox played a significant role in the development of FDA's final rule on tobacco products; the high-profile issue is receiving renewed attention after an agency-commissioned panel sent a report to FDA suggesting the agency regulate the manufacture, marketing and labeling of such items

Topics

UsernamePublicRestriction

Register

PS092154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel